Erythropoetin Stimulating Agents and Chemotherapy Induced Anemia - Emerging Safety Concerns. Erythropoetin Stimulating Agents (ESA’s) are approved to treat anemia in cancer patients…Learn more >

FDA Alert – New Avandia Warning Information Reflects Possible Heart Attack Risk. The FDA informed healthcare professionals of new information about potential increased risk for heart attacks added to the existing boxed warning in Avandia's prescribing information…Learn more >

Pharmacy Claims Processor Conversion Q&A. Recently you may have heard that RegenceRx has decided to partner with a new claims processing vendor Learn more >